Larval therapy for leg ulcers (VenUS II): randomised controlled trial. - Wikidata - awgldk - TriplyDB

Larval therapy for leg ulcers (VenUS II): randomised controlled trial.

Larval therapy for leg ulcers (VenUS II): randomised controlled trial.

http://www.wikidata.org/entity/Q34658264

about

Mechanisms of maggot-induced wound healing: what do we know, and where do we go from here?Practices and impact of primary outcome adjustment in randomized controlled trials: meta-epidemiologic study Traditional Therapies for Skin Wound Healing Maggot excretions affect the human complement system Maggot debridement therapy for the treatment of diabetic foot ulcers: a meta-analysis Survival analysis.A novel approach to the antimicrobial activity of maggot debridement therapy Maggot debridement therapy: a systematic review.Venous ulcers of the lower limb: Where do we stand?Cost effectiveness analysis of larval therapy for leg ulcers.Maggot debridement: an alternative method for debridement.Maggot debridement therapy in the treatment of complex diabetic wounds Maggots as potential vector for pathogen transmission and consequences for infection control in waste management.The Debrisoft(®) Monofilament Debridement Pad for Use in Acute or Chronic Wounds: A NICE Medical Technology Guidance A pilot randomised controlled trial of negative pressure wound therapy to treat grade III/IV pressure ulcers [ISRCTN69032034].Patients' perceptions and experiences of venous leg ulceration and their attitudes to larval therapy: an in-depth qualitative study.Leg ulcers in sickle cell disease: current patterns and practices.A review of maggot debridement therapy to treat chronic wounds.Increasing the options for management of large and complex chronic wounds with a scalable, closed-system dressing for maggot therapy.The efficacy of maggot debridement therapy--a review of comparative clinical trials.Maggot therapy: a literature review of methods and patient experience.The use of larval therapy to reduce the bacterial load in chronic wounds.Complement activation and inhibition in wound healing.Adjunct methods of the standard diabetic foot ulceration therapy Multiple actions of Lucilia sericata larvae in hard-to-heal wounds: larval secretions contain molecules that accelerate wound healing, reduce chronic inflammation and inhibit bacterial infection.Maximising the secondary beneficial effects of larval debridement therapy.TIME management by medicinal larvae.Does maggot therapy promote wound healing? The clinical and cellular evidence.A single-arm trial indirect comparison investigation: a proof-of-concept method to predict venous leg ulcer healing time for a new acellular synthetic matrix matched to standard care control.Optimizing Technology Use for Chronic Lower-Extremity Wound Healing: A Consensus Document.Pain related to maggot debridement therapy.Benefits of maggot debridement therapy on leg ulcers: a literature review.Viability of Lucilia sericata maggots after exposure to wound antiseptics.Selective Antibiofilm Effects of Lucilia sericata Larvae Secretions/Excretions against Wound Pathogens.Maggots as a wound debridement agent for chronic venous leg ulcers under graduated compression bandages: A randomised controlled trial.Growth and Survival of Bagged Lucilia sericata Maggots in Wounds of Patients Undergoing Maggot Debridement Therapy Degradation of MSCRAMM target macromolecules in VLU slough by Lucilia sericata chymotrypsin 1 (ISP) persists in the presence of tissue gelatinase activity.Maggot therapy for wound care in Iran: a case series of the first 28 patients.Wound debridement potential of glycosidases of the wound-healing maggot, Lucilia sericata.Low dose aspirin as adjuvant treatment for venous leg ulceration: pragmatic, randomised, double blind, placebo controlled trial (Aspirin4VLU).

P2860

Q21284686-E5875DE1-ABAA-4B46-8C8B-F289A5877E85 Q24289045-606C163E-EC1C-43F1-AAB5-CEE4FC2E6478 Q26748518-56ABD35B-F273-4A92-88B7-D5815D0821CD Q28278228-6FC8ABFC-9227-480B-AC9D-600A3DF34B6A Q28297918-6E6105BE-A1ED-49E0-9B98-E398300CE25B Q30485623-3C079F88-9DAF-4533-AFC3-A19E7C3C7E8C Q33602668-FE20474B-58EA-4299-A5EF-A8AA7D56BC29 Q34452208-090C9AF8-0725-46FC-8DCA-228440A0C354 Q34480788-A4588392-5B19-4BDC-BDD7-FDCB2084236B Q34605671-864594B9-F92F-4800-BDB7-C7D505E2180B Q35105539-8BEDAEBD-67FB-4B7A-B434-7B53403607B1 Q35600044-EC2E354B-D683-410E-9EA3-BFFB2213DB37 Q35651411-F57069DB-3CD6-487C-BB43-353A88FAC211 Q36322936-A61592BF-9A40-4837-A5AA-C507FC5F0AAD Q36498798-D7DE1883-5E8A-4E0D-9541-D9AD0DFA6584 Q37333292-E32CA776-A4B4-44F1-A3EA-96AF602D34DC Q37394381-D8035B24-1F5F-4134-B8B1-3B8F43E030E3 Q37804754-106EE4BF-872B-4C1F-8178-1381DEA9D39C Q37943692-20E59B9D-93A1-45E8-A977-E1CE1114C1A0 Q37976126-2D0E802E-336F-45A1-9C62-8714ED14ABEA Q38001439-A82CBFA7-A0AA-455B-8511-0269B7FD2333 Q38010037-F363CE15-9535-4979-921C-48FB6B0E2753 Q38076419-875FB0AE-C378-45FC-8019-0ECFBE9E923A Q38120754-58F29FA3-2BA8-480D-A9DC-41D2034982CA Q38152372-3D35F6F0-2BB3-45D7-B4D6-BFA3C7FCF7A1 Q38162351-78D92737-74F2-4B5A-88EE-02B7D63593F2 Q38548116-DAA7FE31-487D-46BC-8159-0A78F7A84522 Q38675562-D06EDDF7-05B9-42BA-86EB-9F4B02DD9B28 Q38792884-3D99F486-9DF9-4944-8971-79E8A7F5BE1A Q38840488-3885BE26-5A4F-4E90-9B48-6C094ECA36EB Q39280633-7E40983D-159B-4D62-80B8-77833249343B Q39343686-0232864F-E03E-4AFA-9135-9FBF54318FC3 Q40619322-49DE2713-2FA3-43CE-941B-811392759A7C Q41464670-D0302350-F42A-41DA-B222-29012EF4DD59 Q41708640-E4481050-F323-4BA0-BDAF-DCAAA78CFB14 Q42052254-EBE7981E-AF99-4B23-B3F7-533286F69883 Q43845612-CCD21758-7477-43EF-86C8-3A1F0360BD49 Q45977633-2DF7FB14-A58F-4331-8F0C-D4DD497A8726 Q46858306-471C9975-8BEB-4260-82D7-061A25790C60 Q47094267-65F46378-DADB-4CE6-8E78-23D5FD1128C4

P2860

Larval therapy for leg ulcers (VenUS II): randomised controlled trial.

http://www.wikidata.org/entity/Q34658264

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Larval therapy for leg ulcers (VenUS II): randomised controlled trial.

@ast

Larval therapy for leg ulcers (VenUS II): randomised controlled trial.

@en

Larval therapy for leg ulcers

@nl

type

label

Larval therapy for leg ulcers (VenUS II): randomised controlled trial.

@ast

Larval therapy for leg ulcers (VenUS II): randomised controlled trial.

@en

Larval therapy for leg ulcers

@nl

prefLabel

Larval therapy for leg ulcers (VenUS II): randomised controlled trial.

@ast

Larval therapy for leg ulcers (VenUS II): randomised controlled trial.

@en

Larval therapy for leg ulcers

@nl

P1433

Q34658264-BDD57787-8B65-4C8F-B185-AA7EB46FA37C

P1476

Q34658264-92D0EEA3-B3F6-44EF-AF6C-4919AD6BCC7A

P2093

Q34658264-14B5BCB8-EFA6-433A-85B5-7AB6C79EB9E3

Q34658264-333C234A-2312-4A85-B23F-D72B468499E3

Q34658264-5BC9F251-2EED-4086-BB2F-32F8F5127AD7

Q34658264-D23D89BB-9623-46D9-B2A1-7CF2C2C981BB

Q34658264-FDCA4740-80F7-4BD0-891A-E07BA01B278C

P2860

Q34658264-118D129D-C778-496B-B461-9E7EA711514F

Q34658264-14670827-1581-432E-B951-72C179DDB2A4

Q34658264-16D83F70-E91A-47B5-A355-69A96EB46340

Q34658264-20192F7D-9B3C-464E-9BD3-F1581EB558AB

Q34658264-2FFACDF8-BDA1-400E-A051-A3263702861D

Q34658264-31B52F89-DE52-43C8-BCC7-DCBD94946EB5

Q34658264-33BC289C-F335-48ED-9CCE-253030787C8E

Q34658264-35722979-5EDD-4FD5-8B5A-5B9F263E1C30

Q34658264-398D86CE-60E7-43F2-A8FB-0DE3B29D116A

Q34658264-436965EE-0BEF-43EE-9967-386BE74EA7C0

P304

Q34658264-A66AFC82-39CC-421B-BF11-9BC438BDDDCB

P31

Q34658264-72409DE7-203F-4669-B373-FFE77FA8967C

P356

Q34658264-F4A6B010-653D-4F51-BB9A-B2F46D9DAFEE

P407

Q34658264-4C0A2212-CEA4-4B43-8811-32E42B552B54

P478

Q34658264-BC79FF7E-524F-4CBF-B66E-C9E5A6DF6FB0

P50

Q34658264-13B25CE6-80B7-4DC8-858B-22D16BFD48A3

Q34658264-30D22FBD-E6AE-4FAF-9997-9EA994F59FB4

Q34658264-41A9D631-01BA-4DC0-A044-C75A3C0EB177

Q34658264-80384F60-CF6C-4E76-862C-9A67B783997D

Q34658264-98C2C874-4C08-4C6A-A42C-884D548C4D53

Q34658264-BFCDD0A1-4640-43A2-A9AD-B10F7B56E70C

P577

Q34658264-DBE6E4F8-5D0B-4E78-A6B4-1C8DB3A8870C

P5875

Q34658264-6B6587FA-B1B0-437C-ADB9-99B7A922BB74

P698

Q34658264-78DE9F61-83AC-4D6D-8073-1B81A687301E

P932

Q34658264-A64F2CA5-6DDA-4B3C-987F-DDC0807CFC7C

P356

P1433

P1476

Larval therapy for leg ulcers (VenUS II): randomised controlled trial

@en

P2093

Cynthia Iglesias

http://www.w3.org/2001/XMLSchema#string

Gill Worthy

http://www.w3.org/2001/XMLSchema#string

J Martin Bland

http://www.w3.org/2001/XMLSchema#string

Joanne L Mitchell

http://www.w3.org/2001/XMLSchema#string

VenUS II team

http://www.w3.org/2001/XMLSchema#string

P2860

Medicinal maggots: an ancient remedy for some contemporary afflictions

Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa

Destruction of bacteria in the digestive tract of the maggot of Lucilia sericata (Diptera: Calliphoridae).

Systematic reviews of wound care management: (5) beds; (6) compression; (7) laser therapy, therapeutic ultrasound, electrotherapy and electromagnetic therapy.

Antibacterial properties of whole body extracts and haemolymph of Lucilia sericata maggots.

Compression bandages and stockings for venous leg ulcers.

Maggot therapy: a review of the therapeutic applications of fly larvae in human medicine, especially for treating osteomyelitis.

Using larvae in modern wound management.

Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon the migration of human dermal fibroblasts over a fibronectin-coated surface.

Maggot therapy for subacute mastoiditis.

P304

b773

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.B773

http://www.w3.org/2001/XMLSchema#string

P407

P478

338

http://www.w3.org/2001/XMLSchema#string

P50

David J. Torgerson

Christopher G. Dowson

P577

2009-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24218008

http://www.w3.org/2001/XMLSchema#string

P698

19304577

http://www.w3.org/2001/XMLSchema#string

P932

2659858

http://www.w3.org/2001/XMLSchema#string